DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Robinson DS, Kajdasz DK, Gallipoli S. et al.
A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder.
J Clin Psychopharmacol. 2011;
31: 643-646
Access:
We do not assume any responsibility for the contents of the web pages of other providers.